Neftaly: Developing Partnerships for Sustainable Funding of Biomarker Research
Introduction
Biomarker research is transforming healthcare by enabling early disease detection, personalized treatment, and targeted public health interventions. However, sustaining this progress requires long-term, reliable funding — particularly in low- and middle-income countries where resources are limited and needs are high.
At Neftaly, we believe that the key to advancing biomarker science lies in building strategic, multi-sector partnerships that align research goals with national health priorities, innovation agendas, and global development efforts.
Why Sustainable Funding Matters
- Accelerates Innovation: Ensures continuity of research and development, from discovery to clinical application.
- Strengthens Health Systems: Supports integration of biomarkers into routine care, surveillance, and policy.
- Enables Equity: Makes biomarker-based diagnostics and treatments accessible across diverse populations.
- Builds Local Capacity: Funds training, infrastructure, and workforce development for long-term impact.
Key Partnership Strategies for Funding Biomarker Research
1. Align with National and Global Priorities
- Link biomarker research to pressing health issues such as infectious diseases, maternal health, cancer, or environmental exposures.
- Frame proposals within the context of SDGs, Universal Health Coverage, or pandemic preparedness to attract donor interest.
2. Leverage Public-Private Partnerships (PPPs)
- Collaborate with biotech firms, pharmaceutical companies, and diagnostic developers to co-invest in translational research.
- Offer opportunities for shared intellectual property, field testing, or access to local markets.
3. Engage Multilateral and Philanthropic Donors
- Build relationships with organizations such as the WHO, Global Fund, Gates Foundation, Wellcome Trust, and others that prioritize health innovation.
- Submit aligned proposals that demonstrate scalability, health impact, and equity.
4. Foster Academic and Research Institution Alliances
- Partner with universities and global research centers to apply for joint grants, share infrastructure, and co-publish findings.
- Promote South-South collaborations to boost regional leadership and knowledge sharing.
5. Advocate for Domestic Investment
- Work with ministries of health, science, and finance to include biomarker research in national budgets and innovation roadmaps.
- Present biomarker research as a tool for health system strengthening and cost-effective care.
6. Utilize Innovative Financing Mechanisms
- Explore blended finance, social impact bonds, and pooled funds to support research that delivers both social and economic returns.
- Encourage venture capital and health-tech investors to fund pilot innovations with long-term scale-up potential.
Neftaly’s Role in Partnership Development
Neftaly supports stakeholders to:
- Map potential funders and research collaborators aligned with national and regional goals
- Develop compelling investment cases and funding proposals
- Facilitate cross-sector convenings to build trust and shared agendas
- Provide technical assistance in grant writing, budgeting, and project planning
- Advocate for policy environments that support research financing and data-sharing
Conclusion
Sustainable funding is the cornerstone of impactful biomarker research. Through smart, inclusive, and strategic partnerships, we can unlock innovation, bridge the research-to-action gap, and build resilient health systems that leave no one behind.